Press Release: PurMinds NeuroPharma Announces Its First Botanical Psilocybin Delivery to Bluestem API Inc.

5 months ago

Published: Jun 18, 2024 Toronto, Ontario and Boston, Massachusetts–(Newsfile Corp. – June 18, 2024) – PurMinds NeuroPharma (“PurMinds” or the “Company”), a neuro-medicine development company focused on advancing novel therapeutics for neurological and neurodegenerative disorders, today announced that it has signed the first Controlled Substances Supply Agreement with Bluestem API Inc (“Bluestem”) to produce and […]